Net Loss of Panacea Biotec reported to Rs 1.99 crore in the quarter ended March 2024 as against net loss of Rs 12.68 crore during the previous quarter ended March 2023. Sales rose 5.84% to Rs 136.46 crore in the quarter ended March 2024 as against Rs 128.93 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 1.50 crore in the year ended March 2024 as against net loss of Rs 33.75 crore during the previous year ended March 2023. Sales rose 21.57% to Rs 559.17 crore in the year ended March 2024 as against Rs 459.95 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales136.46128.93 6 559.17459.95 22 OPM %-4.43-4.40 --3.59-21.30 - PBDT3.958.34 -53 2.16-50.74 LP PBT-4.86-1.17 -315 -34.55-89.86 62 NP-1.99-12.68 84 -1.50-33.75 96 Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Net profit of Panacea Biotec declined 96.75% to Rs 0.43 crore in the quarter ended December 2023 as against Rs 13.24 crore during the previous quarter ended December 2022. Sales rose 32.32% to Rs 95.23 crore in the quarter ended December 2023 as against Rs 71.97 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales95.2371.97 32 OPM %6.9717.08 - PBDT6.2819.32 -67 PBT1.0713.24 -92 NP0.4313.24 -97 Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 8 February 2024.Powered by Capital Market - Live News